Schedule 13G ownership disclosure

Oruka Therapeutics Inc

Common Stock · CUSIP: 687604108

Event date: 2026-03-13

Filing-level shares
0
Percent of class
0%
  • The Vanguard Group

    Shares: 0 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000102909-26-001923
Form type
SCHEDULE 13G/A
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Mar 27, 2026
Reporting period
Mar 13, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub